The new vaccine uses empty protein shell of the virus, which induces immunity in the animal against the virus. Early trials have produced remarkable results and have the same efficiency as the vaccine formed with live virus. Moreover, it is convenient to store without costly storage equipments.
Synthetic vaccines have made it possible to distinguish between infected animals and vaccinated animals.
Researchers opine that the synthetic vaccines are safe and do not cause infection.
The authors suggest that further research and clinical trials are required to determine the safety and efficiency of the vaccine.